NO306535B1 - Opthalmisk topisk blanding inneholdende (S)-timololhemihydrat - Google Patents

Opthalmisk topisk blanding inneholdende (S)-timololhemihydrat

Info

Publication number
NO306535B1
NO306535B1 NO950059A NO950059A NO306535B1 NO 306535 B1 NO306535 B1 NO 306535B1 NO 950059 A NO950059 A NO 950059A NO 950059 A NO950059 A NO 950059A NO 306535 B1 NO306535 B1 NO 306535B1
Authority
NO
Norway
Prior art keywords
compsn
adjusters
pref
composition containing
topical composition
Prior art date
Application number
NO950059A
Other languages
English (en)
Other versions
NO950059L (no
NO950059D0 (no
Inventor
Markku Perolampi
Kari Lehmussaari
Olli Oksala
Esko Pohjala
Timo Reunamoki
Jarkko Ruohonen
Original Assignee
Santen Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Oy filed Critical Santen Oy
Publication of NO950059L publication Critical patent/NO950059L/no
Publication of NO950059D0 publication Critical patent/NO950059D0/no
Publication of NO306535B1 publication Critical patent/NO306535B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO950059A 1992-07-08 1995-01-06 Opthalmisk topisk blanding inneholdende (S)-timololhemihydrat NO306535B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91066592A 1992-07-08 1992-07-08
PCT/FI1993/000269 WO1994001115A1 (en) 1992-07-08 1993-06-23 Ophthalmic topical composition containing (s)-timolol hemihydrate

Publications (3)

Publication Number Publication Date
NO950059L NO950059L (no) 1995-01-06
NO950059D0 NO950059D0 (no) 1995-01-06
NO306535B1 true NO306535B1 (no) 1999-11-22

Family

ID=25429138

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950059A NO306535B1 (no) 1992-07-08 1995-01-06 Opthalmisk topisk blanding inneholdende (S)-timololhemihydrat

Country Status (21)

Country Link
EP (1) EP0577913B1 (no)
JP (1) JP3094233B2 (no)
KR (1) KR100278851B1 (no)
AT (1) ATE154513T1 (no)
AU (1) AU678972B2 (no)
BR (1) BR9306800A (no)
CA (1) CA2139781C (no)
CZ (1) CZ282168B6 (no)
DE (1) DE69220484T2 (no)
DK (1) DK0577913T3 (no)
EE (1) EE03078B1 (no)
ES (1) ES2106852T3 (no)
FI (1) FI112321B (no)
GR (1) GR3024648T3 (no)
HK (1) HK1007503A1 (no)
HU (1) HU221618B1 (no)
NO (1) NO306535B1 (no)
NZ (1) NZ253164A (no)
PL (1) PL172503B1 (no)
SG (1) SG49770A1 (no)
WO (1) WO1994001115A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2317650T3 (es) 1996-10-28 2009-04-16 Senju Pharmaceutical Co., Ltd. Farmacos para mejorar trastornos circulatorios oculares.
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
WO2004098592A1 (ja) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. オキサゾリジノン誘導体含有組成物
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
JP2014024794A (ja) * 2012-07-27 2014-02-06 Nippon Tenganyaku Kenkyusho:Kk チモロールまたはその薬学的に許容される塩を含有する水性組成物およびその光安定化方法
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195085A (en) 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
NZ196227A (en) * 1980-02-19 1984-09-28 Merck & Co Inc 1,2,5-thiadiazole derivative and ophthalmic compositions
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
FI82240C (fi) 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.

Also Published As

Publication number Publication date
SG49770A1 (en) 1998-06-15
DE69220484D1 (de) 1997-07-24
CA2139781A1 (en) 1994-01-20
WO1994001115A1 (en) 1994-01-20
KR100278851B1 (ko) 2001-01-15
FI950050A0 (fi) 1995-01-04
EP0577913A1 (en) 1994-01-12
GR3024648T3 (en) 1997-12-31
KR950702422A (ko) 1995-07-29
DE69220484T2 (de) 1998-02-05
HUT72657A (en) 1996-05-28
JP3094233B2 (ja) 2000-10-03
AU678972B2 (en) 1997-06-19
NZ253164A (en) 1996-01-26
AU4329693A (en) 1994-01-31
HK1007503A1 (en) 1999-04-16
ES2106852T3 (es) 1997-11-16
NO950059L (no) 1995-01-06
NO950059D0 (no) 1995-01-06
JPH07508745A (ja) 1995-09-28
CZ4495A3 (en) 1995-09-13
PL307051A1 (en) 1995-05-02
CA2139781C (en) 2003-09-23
HU221618B1 (hu) 2002-12-28
EE03078B1 (et) 1998-04-15
EP0577913B1 (en) 1997-06-18
CZ282168B6 (cs) 1997-05-14
PL172503B1 (pl) 1997-10-31
BR9306800A (pt) 1998-12-08
FI112321B (fi) 2003-11-28
DK0577913T3 (da) 1998-01-26
ATE154513T1 (de) 1997-07-15
HU9500035D0 (en) 1995-03-28
FI950050A (fi) 1995-01-04

Similar Documents

Publication Publication Date Title
ATE151640T1 (de) Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel
ES2098739T3 (es) Composiciones oftalmicas conteniendo una cyclosporin.
MX173433B (es) Composicion acuosa de ibuprofen y procedimiento para su preparacion
ES2184836T3 (es) Composiciones que contienen derivados de azol para aplicacion topica en la piel.
DK47189D0 (da) Bredspektret konserveringsmiddel med synergistisk biocidvirkning
FI88459B (fi) Foerfarande foer framstaellning av en foer intranasal applikation laemplig steroidkomposition
ES2098672T3 (es) Composiciones farmaceuticas estabilizadas que contienen derivados de vitaminas d2 y d3.
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.
NO306535B1 (no) Opthalmisk topisk blanding inneholdende (S)-timololhemihydrat
ES2113358T3 (es) Composiciones antidiarreicas.
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
ES2037829T3 (es) Agentes contra el glaucoma a base de tiofen sulfonamida.
FI961336A (fi) Menetelmä silmänesteiden säilömiseksi ja koostumuksia tätä varten
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
DE3866281D1 (de) Flunarizin enthaltende zusammensetzungen.
AR002281A1 (es) Compuesto antimigrana derivado del 1,2,5-tiadiazol de las indolilalquil- piridinil y pirimidinil-piperazina, composicion farmaceutica que lo contiene
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
HUT66153A (en) Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
KR890701081A (ko) 장기간 지속 모발변형제 및 그 사용방법
DK0593520T3 (da) Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom
KR880011161A (ko) Ll-f 28249 화합물의 모노-및 디에폭시드 유도체와 그의 사용방법 및 그 유도체를 포함하는 조성물
ATE33759T1 (de) Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle.
MX9306467A (es) Formulacion novedosa.
RU95106983A (ru) Офтальмологический состав, способ его получения и средство для офтальмологического состава
IT227086Y1 (it) Confezione per sigarette e simili

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees